Spectrum Wealth Counsel’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
MMEA
Spectrum Wealth Counsel's IBB Position: Q1 2025 in Review
Spectrum Wealth Counsel held its iShares Biotechnology ETF (IBB) position steady in Q1 2025 at 150 shares worth $19.2K. The position accounts for ﹤0.01% of the portfolio, ranked #205.
Spectrum Wealth Counsel first reported a position in IBB in Q4 2023 and has held it in 6 quarters since. The position peaked at $23.7K in Q2 2024. 831 funds tracked by Wall St. Rank hold IBB as of Q1 2025.
- Spectrum Wealth Counsel held 150 shares of iShares Biotechnology ETF worth $19.2K as of Q1 2025.
- Spectrum Wealth Counsel left its iShares Biotechnology ETF share count unchanged in Q1 2025.
- iShares Biotechnology ETF made up ﹤0.01% of Spectrum Wealth Counsel's portfolio in Q1 2025, its #205 holding.
- Spectrum Wealth Counsel first reported a position in iShares Biotechnology ETF in Q4 2023 and has held it in 6 quarters since.
- Spectrum Wealth Counsel's iShares Biotechnology ETF position peaked at $23.7K in Q2 2024.
- 831 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2025.
Based on Spectrum Wealth Counsel's 13F filing for Q1 2025, filed 7 May 2025.